Biology Reference
In-Depth Information
Pakala, R., Watanabe, T., Benedict, C.R., 2002. Induction of endothelial cell proliferation by
angiogenic factors released by activated monocytes. Cardiovasc. Radiat. Med. 3, 95-101.
Palumbo, J.S., Degen, J.L., 2007. Mechanisms linking tumor cell-associated procoagulant
function to tumor metastasis. Thromb. Res. 120 (Suppl. 2), S22-S28.
Paulus, P., Stanley, E.R., Schafer, R., Abraham, D., Aharinejad, S., 2006. Colony-stimulating
factor-1 antibody reverses chemoresistance in human MCF-7 breast cancer xenografts.
Cancer Res. 66, 4349-4356.
Pello, O.M., De, P.M., Mirolo, M., Soucek, L., Zammataro, L., Amabile, A., Doni, A., Nebu-
loni, M., Swigart, L.B., Evan, G.I., Mantovani, A., Locati, M., 2012. Role of c-MYC in
alternative activation of human macrophages and tumor-associated macrophage biology.
Blood 119, 411-421.
Piras, F., Colombari, R., Minerba, L., Murtas, D., Floris, C., Maxia, C., Corbu, A., Perra,
M.T., Sirigu, P., 2005. The predictive value of CD8, CD4, CD68, and human leukocyte
antigen-D-related cells in the prognosis of cutaneous malignant melanoma with vertical
growth phase. Cancer 104, 1246-1254.
Pollard, J.W., 2004. Tumour-educated macrophages promote tumour progression and metas-
tasis. Nat. Rev. Cancer 4, 71-78.
Qayum, N., Im, J., Stratford, M.R., Bernhard, E.J., McKenna, W.G., Muschel, R.J., 2012.
Modulation of the tumor microvasculature by phosphoinositide-3 kinase inhibition
increases doxorubicin delivery
in vivo
. Clin. Cancer Res. 18, 161-169.
Qian, B.Z., Pollard, J.W., 2010. Macrophage diversity enhances tumor progression and
metastasis. Cell 141, 39-51.
Qian, B.Z., Li, J., Zhang, H., Kitamura, T., Zhang, J., Campion, L.R., Kaiser, E.A., Snyder,
L.A., Pollard, J.W., 2011. CCL2 recruits inflammatory monocytes to facilitate breast-
tumour metastasis. Nature 475, 222-225.
Reggiori, F., Klionsky, D.J., 2002. Autophagy in the eukaryotic cell. Eukaryot. Cell 1, 11-21.
Roca, H., Varsos, Z.S., Sud, S., Craig, M.J., Ying, C., Pienta, K.J., 2009. CCL2 and interleu-
kin-6 promote survival of human CD11b+ peripheral blood mononuclear cells and
induce M2-type macrophage polarization. J. Biol. Chem. 284, 34342-34354.
Rolny, C., Mazzone, M., Tugues, S., Laoui, D., Johansson, I., Coulon, C., Squadrito, M.L.,
Segura, I., Li, X., Knevels, E., Costa, S., Vinckier, S., Dresselaer, T., Akerud, P., De, M.M.,
Salomaki, H., Phillipson, M., Wyns, S., Larsson, E., Buysschaert, I., Botling, J., Himmel-
reich, U., Van Ginderachter, J.A., De, P.M., Dewerchin, M., Claesson-Welsh, L., Car-
meliet, P., 2011. HRG inhibits tumor growth and metastasis by inducing macrophage
polarization and vessel normalization through downregulation of PlGF. Cancer Cell 19,
31-44.
Ryder, M., Ghossein, R.A., Ricarte-Filho, J.C., Knauf, J.A., Fagin, J.A., 2008. Increased den-
sity of tumor-associated macrophages is associated with decreased survival in advanced
thyroid cancer. Endocr. Relat. Cancer 15, 1069-1074.
Saccani, A., Schioppa,T., Porta, C., Biswas, S.K., Nebuloni, M.,Vago, L., Bottazzi, B., Colombo,
M.P., Mantovani, A., Sica, A., 2006. p50 nuclear factor-kappaB overexpression in tumor-
associated macrophages inhibits M1 inflammatory responses and antitumor resistance.
Cancer Res. 66, 11432-11440.
Salvesen, H.B., Akslen, L.A., 1999. Significance of tumour-associated macrophages, vascular
endothelial growth factor and thrombospondin-1 expression for tumour angiogenesis
and prognosis in endometrial carcinomas. Int. J. Cancer 84, 538-543.
Sawano, A., Takahashi, T., Yamaguchi, S., Aonuma, M., Shibuya, M., 1996. Flt-1 but not
KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to
vascular endothelial growth factor. Cell. Growth Differ 7, 213-221.
Sawano, A., Iwai, S., Sakurai, Y., Ito, M., Shitara, K., Nakahata, T., Shibuya, M., 2001. Flt-1,
vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lin-
eage of monocyte-macrophages in humans. Blood 97, 785-791.
Search WWH ::
Custom Search